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First aerospace medical elective in
Arizona given birth by physician
BY DAVID BRYMAN, D.O.
Tamisiea Award. Dr. Manuel Rico Jaime (center),
receives the 2003 Tamisiea plaque from CAMA
President Dr. Robin E. Dodge (right) and AsMA
President Dr. Claude Thibeault.
This year's recipient of CAMA's top
award, the Tamisiea Memorial Award, went
to Brig. Gen. Victor Manuel Rico Jaime,
M.D., "for his contribution in the applica-
tion of the art and science of aviation medi-
cine and to general and commercial avia-
tion over the past 22 years..." Dr. Rico Jaime
designed and implemented a primary course
in aviation medicine for military and civil-
ian AMEs in Mexico. He serves as an AME
for both Mexico and the US Federal Avia-
tion Administration. FP
Ar THE DECEMBER 2002 CAMA Boardneeting in Dallas, Dr. Dodge proposed
that the board members consider contacting
their local medical schools to discuss the pos-
sibility of offering medical students some lec-
tures in Aerospace Medicine. The idea of in-
troducing students to this subject was to
broaden their educational experience and
pique their interest in choosing Aerospace
Medicine as a career.
Designing and implementing an aero-
space curriculum intrigued me. I contacted
Dr. McWilliams, Associate Dean of Mid-
western University at the Arizona College
of Osteopathic Medicine and presented him
with a formal proposal and course outline.
The curriculum committee met shortly
thereafter and unanimously approved the
Continued on page 5
How Not to Perform a Flight Physical
Most pilots go to great lengths to comply with FAA medical reporting requirements.
But, there are a few who will go to equally great lengths to conceal a serious problem.
(Plus other potential pitfalls confronting each "new generation" of AMEs.)
BY STACY VEREEN, M.D.
'TT'he FAA flight physical: If it were a per-
-L son rather than a concept, it would truly
have my sympathy! It was doomed to unpopu-
larity from the beginning.
Think about it! It's mandatory. It costs
money. And the government regulates it. If
that weren't enough, the findings from this
physical could swiftly bring an end to
anyone's flying career or avocation. As
AMEs or flight surgeons, we are called upon
to perform this physical exam and use our
findings to ultimately decide on three pos-
sible courses of action: deny, defer, or issue.






FOR SEVERAL REASONS, I feelthat the effort expended torebuild CAMA and its in-
frastructure over the last decade
is showing signs of success.
1— CAMA is better known now
so that when it is mentioned in a
conversation, it does not evoke a
blank stare.
2—The number and type of con-
tacts or requests received at the
Home Office. A number of these
are from sources that have not
previously been in the habit of
dealing with CAMA.
3— The CAMA Sunday session
held in conjunction with the an-
nual Aerospace Medical Associa-
tion scientific meeting.
The second annua l CAMA
Sunday was recently held in San
Anton io . The qua l i t y of the
speakers who agreed to give pre-
sentations and their general posi-
tive response to the event after-
wards speaks well for CAMA.
This also indicates the planning
orchestrated by Dr. Jack Hastings,
was a professional effort.
We would like to see the audi-
ence grow a little faster, and are
working on an improved advance
notification system for next year




BY ROBIN E. DODGE, MD
The cu r r en t CAMA gover-
nance team does not condone the
status quo as an acceptable atti-
tude. Improving, updating, and
developing new approaches—
while ensuring that current solid
practices are maintained—are the
essential elements in moving an
organization forward.
To this end, at the Board of
Trustees meeting in San Antonio,
an updated draft of CAMA's con-
s t i tu t ion and by-laws was re-
viewed. Also, an ad hoc commit-
tee was created and tasked to look
into productive ways to engage
fellow medical associations in
meaningful dialogue about the
role of front- l ine, primary-care
physicians in dealing with the ill
and injured flying public.
The Age 60 Rule continues to
simmer along, coming to a boil
periodically. Just prior to the re-
cent Board meeting, CAMA was
asked to comment on its current
66It is an exciting time to be
a leader or member of a
premier aeromedical asso-
ciation whose membership
is on the front lines*
position on the issue. The Board
confirmed that the press release,
as posted on our Web site, reflects
our position and that it is not a
medical issue.
The recent SARS ou tb reak
combined with the depressed eco-
nomic circumstances of the air-
lines, has created conditions ripe
for major stress. This is particu-
larly important for the Aviation
Medical Examiner when dealing
with his airline pilot clientele.
The AME must be leery of the
effect(s) that these stressors might
have on the pilot's health.
All in all, it is a busy time to
be involved with the aeromedical
aspects of flight safety. However,
it is also an exciting time to be a
leader or member of a premier
aeromedical association whose
membership is on the front lines.
So, if you are not yet a mem-
ber of the Civil Aviation Medical
Association, visit our Web site's
application page—
http://civilavmed.com/ap.htm
and become an active CAMA
team member.
Have a good, healthy, and safe
summer. FP
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Oklahoma City, OK 73123
(405)840-0199
Fax: (405) 848-1053
BY JIM ALMAND, MD
It is a pleasure to report the health ofour organization. We continue to
flourish. Our membership status con-
tinues to increase and the financial sta-
bility of the organization remains quite
healthy. All CAMA-supported and di-
rected educational programs and activi-
ties are on-line and excellently managed.
Your management team needs some
input, particularly in the Secretary-
Treasurer position, due to the illness
of the current owner of that chair.
However, your President is making
steps in that direction.
Next, of particular recognition, is the
success of CAMA Sunday scientific ses-
sion, coordinated yearly with the annual
Aerospace Medical Association meeting.
Should it be possible, CAMA should
further investigate mutual support in the
meetings and programs sponsored by the
Airline Medical Directors Association.
In conclusion, it's been quite satis-
factory to watch the progress of CAMA's
dedicated management team over the
last year. The future of the association
continues to look bright and secure.
Newsletter Progress
This year, the Civil Aviation Medi-
cal Association's Flight Physician has
been the source of challenges, interest,
perseverance, and a few hard knocks!
Meeting deadlines of issues for the news-
letter every two months has been a re-
warding experience and has resulted in
a very active voice for your membership,
as well as outside aviation authorities.
I have recommended that the
editorship of the CAMA Flight Physi-
cian be jointly served by both the ap-
pointed editor and the president-elect,
with both terms to last concurrently and
terminate at the end of the president-
elect's two-year term. In such a format,
a greater appreciation of the mechanics
of publishing the newsletter will be
shared through the editor to the presi-
dent-elect.
The president-elect will support the
newsletter by actively contributing ar-
ticles. Such rotation of duties of dual
editorship of the newsletter on a two-year
basis should result in "hopefully" a fresher
turnover of ideas, editorials, aviation ar-
ticles, and membership stimulus. A
strong emphasis will consistently be
needed in the securing of advertisements
for the newsletter.
Most importantly, our biggest "editor-
in-the-sky" — Executive Vice-President
Jim Harris — is to be recognized as the
greatest contributor to your Flight
Physician's success!
Dr. Bryman New Co-Editor













at Midwestern University in Phoenix, as
well as teaching in the graduate and un-
dergraduate programs at Embry-Riddle
Aeronautical University [see Aerospace
Medical Elective, page 1].
Dr. Bryman is one of CAMA's active
younger members with plenty of writing
capability. Please help him along with




PHYSICAL from page 1
Over my short years of AME
work, I have, from time to time,
made a few pilots very unhappy with
my choice of action in all three cat-
egories. Lest you think it impossible
to upset a pilot with the issuance of
a valid medical certificate, I recount
the following tale: Captain Heavy
(whose name is fictitious, but which
suggest nicely the type of equipment
he flew, not to mention his habitus)
came to me with mild asthma. Oh,
this was no new problem. He'd had
mild symptoms for years, but his
asthma had been well controlled with
an acceptable medication. This time
however, things were different.
"Doc," he said, "I think I want to
hang it up. I think I'll use my asthma
to get an early retirement." After
pulmonary function studies revealed
that his asthma had definitely not
worsened and, in fact, was better than
ever, he was very unhappy.
"What if I quit taking my medi-
cine? Would that do it?" he asked. I
explained to him that there were,
theoretically, many things one could
do to achieve medical disqualifica-
tion. Self-inflicted injury or the in-
tentional mismanagement of a con-
dition or disease or even the fabrica-
tion of symptoms would be possible,
but such course of action would be
unwise on two counts.
First, it could compromise his
health, and second it would be rela-
tively easy to detect. It would also be
dishonest and would necessitate fal-
sifying at least two documents: the
FAA form 8500-8, and the disability
forms from his airline.
Captain Heavy was somewhat less
than exuberant over my interpreta-
tion of Western ethics, but he con-
ceded, "The risks would be too
great..." (This was, of course, his
interpretation of Western ethics and
perhaps a more popular one at that.)
The lessons here are simple. When
disability is involved, keep a modi-
cum of suspicion and quantify all that
you can. When there is a question as
to the validity of a complaint, you
don't have to confront or preach. Do
what I should have done. Just say
those magic words, "Well, we'll send
all this in to the boys in Oklahoma
City and see what they say."
One of the most tempting traps
to fall into is what I call "certifica-
tion on the come." That is when you
issue a certificate on good faith ex-
pecting a hard copy confirmation of
something or other. An example (re-
grettably from my own files) follows:
Sid Stone (not his real name, but
if I tell you Sid was short for residual,
it will begin to make sense later)
called the office late one afternoon
desperately needing a second-class
flight physical. We agreed to "work
him in," and so he was the last thing
for me between a hard day and a hot
dinner.
When I reviewed his history on
the front of the Form 8500-8, I no-
ticed 18J was checked and "kidney
stone 2 years ago" was written in the
comments field below it. Sid ex-
plained, "I had a pain in the right
side of my back, so I went to my fam-
ily doctor, and he did an X-ray. Later
that night, the stone passed. I went
back to the doctor the next day and
he sent me over to the hospital to get
one of those fancy X-rays with dye
in your veins. Anyway, the X-ray
showed that the stone had passed,
and I have had no problems since
then. Gosh Doc, I've got a job inter-
view in the morning, and I have to
have a current second-class medical
to even get in the door! This isn't go-
ing to delay things is it?"
I explained that normally I would
have to see a copy of the X-ray report
to verify all this, but in this case, I
would let him have a certificate that
day if he would promise to have that
report in my hands the next day. He
promised that as soon as the job in-
terview was over, he would comply
forthwith. He was a man of his word.
The next day, he came to the
clinic, smiling from ear to ear. He had
gotten the job and he also had the
records from his previous bout with
renalithiasis. The radiologist's report
of the IVP showed conclusively that
he had passed the stone.
I would like to think I had been
compassionate and that I did the
right thing. I would like to think that,
but I can't. The IVP showed two ad-
ditional stones in the left renal pel-
vis. I was extremely lucky that every-
thing turned out all right. He wasn't
due to begin his new job for several
weeks, so he opted to have lithotripsy
in the interim, and we managed to
get him recertified shortly thereafter.
What if he had taken to the skies
and had an attack of acute renal colic?
The point is ...verifyTHEN certify.
The reverse is sometimes tempting,
but it can lead to a real scare (or
worse!).
Another variation of trying to put
you on the spot is the "out of the
blue" phone call. "Doc, I have a
friend who just had a bypass. Does
he have to report that to the FAA?"
asked the caller.
"Well, of course," I replied. So far
so good. But then the caller said.
"Well, this friend also asked me what
would happen if he didn't report it
on his next flight physical. What can
you tell me about that?"
I went into the standard diatribe
about fraudulently filling out a gov-
ernment document, and then it sud-
Continued —>
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denly dawned on me to mention that
the scar would prompt some pretty
tough questions at the physical exam.
"Well, Doc, he's got a year and
eight months left on his third-class
physical (funny how he knew to the
month the duration of this friend's
physical) so he's OK 'til then, right?"
was the next question.
"No, not right," I replied, "Read
Part 61.53..."
"OK Doc, thanks a lot," con-
cluded the conversation.
One year and eight months later,
a 54-year-old private pilot, who had
been getting his flight physicals with
me for years, attempted to obtain
third-class certification with a fellow
AME. He reported no health prob-
lems, but did have a curious mid-ster-
nal chest scar that he had cleverly at-
tempted to conceal with an elaborate
chest tattoo.
The lesson, of course: People will
do anything for certification. No one
loves flying half so much as the
grounded pilot. The majority of pi-
lots will go to great lengths to com-
ply with FAA medical reporting re-
quirements. But, there are a few who
will go to equally great lengths to
conceal a serious problem. Watch for
these few! Very often these types will
call an AME "out of the blue and ask
if this or that condition or medica-
tion is approved." Armed with the
latest scoop, they will visit another
AME and fill out their paperwork
accordingly.
Another easy goof-up is the pilot
suffering from Historipenia, the poor
historian. Consider the pilot with
gingival hyperplasia. He presented
with a "clean" history. That is, there
were no "yes" answers on items 17,
18, or 19. He took no medicines and
had no medical encounters. Since he
was 66 years old, I asked him about
his history. He said that everything
was fine: i.e., no hospitalizations, no
serious illnesses, etc. I asked him
about his gingival hyperplasia. "No
medicines," he said.
I was about ready to chalk this one
up to some sort of gum anomaly and
go ahead and certify. But something
prompted me to ask if he'd ever seen
a dentist about his gums. He replied,
"Nope, this gum problem has been
with me since I was in my twenties.
They say it's from my Dilantin."
But you said no medicines," was
my immediate response.
"Well, Doc, I guess technically
Dilantin is a medication but I've been
taking it for 40 years."
"Oh," is all I could muster at this
point.
I won't bore you with the rest of
the details. The gentleman is happy.
He flies with his son who is a com-
mercial pilot, and who, of course,
assumes pilot-in-command duties. As
hard as it may be to believe, I think
the omission was honest.
I have run into this same scenario
several times with insulin, anti-
hypertensives, and antidepressants.
Many people who have been taking
a specific medication for a long time
(usually for some chronic condition)
will fail to report it. This is not be-
cause of any attempt to deceive, but
because they simply don't think of it.
Well, these are the ones I've de-
tected. How many have I missed? I
hope not many. The potential trag-
edy of even one medically-related ac-
cident is horrible, of course. The di-
viding line between flight safety and
freedom to fly is not an easy one to
draw, nor can it always be drawn with
precision. Many pitfalls await us, so
we must be ever vigilant. FP
Author's note: This piece appeared in
the Fall of 1966. I resubmit it here-
with because I believe that each "new
generation" of AMEs goes through
these pitfalls— and many more.
ELECTIVE from page 1
course as a ten-week elective. The
students could be in any year of
their training, as the course had no
prerequisite requirements. Thus,
the first aerospace medical elective
in Arizona was born.
For course materials, I utilized a
variety of videos, Power Point pre-
sentations, and handouts. I had
accumulated most of these items
while teaching at Embry-Riddle
Aeronautical University and lectur-
ing as a safety counselor for the
FAA. I added useful information on
flight physiology and aviation
safety from the Aerospace Medical
Association's Web site, as well as ar-
ticles from the "Blue Journal." Per-
tinent, interactive case studies re-
inforced the new knowledge and
maintained the student's attention.
We began the program by pro-
viding some background informa-
tion on aviation and aerospace
medicine history. We reviewed
available residency programs and
current requirements to obtain
board certification. Case studies
helped the students integrate text-
book information with real-life
situations, especially when we cov-
ered the physiological and psycho-
logical effects that space travel can
have on the human body. We dis-
cussed how the musculoskeletal,
vestibular, and cardiovascular sys-
tems are affected by the zero-grav-
ity environment. They left with an
in-depth understanding of condi-
tions that can elicit hypoxia, hy-
poglycemia, hyperventilation, de-
compression sickness, and many
others, and how the symptoms may
present in the flight environment.
Continued on page 7
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CAMA Members Recognized for Achievements
at 2003 Aerospace Medical Association Meeting




The Won Chuel Kay Award
is presented annually to a












The Theodore C. Lyster
Award is given for out-
standing achievement in
the general field of aero-
space medicine.
The recipient was GLAUS





Two CAMA members were
elected Fellow in the Aero-
space Medical Association.
They were RONALD W.
HANSROTE, M.D., and ALEX
M. WOLBRINK, M.D.
AsMA President Dr. Claude
Thibeault (left) presents the Won
Chuel Kay Award to Dr. Finkelstein.
New AsAAA Fellows.
Above: Dr. Hansrote and Dr. Claude
Thibeault








ELECTIVE from page 5
One class was dedicated to the
anatomy and physiology of vision
and hearing, and how it could be
affected in flight by hypoxia, fa-
tigue, and alcohol. We covered vi-
sual i l lusions— inc luding the
black-hole effect, white-out effect,
and landing illusions. Another class
was dedicated to studying cockpit
resource management, in-flight
medical emergencies, and what
medical equipment one might ex-
pect to find on board a commercial
airliner. We discussed the possible
costs of a medical diversion.
I presented accident scenarios
and actual cases from the NTSB
files on airplane crashes involving
disor ientat ion and s i tuat ional
awareness. The students (and the
instructor) were amazed at the fre-
quency of accidents that involved
CFIT (controlled flight into ter-
rain) due to lost situational aware-
ness. This helped them under-
stand the l imitations of human
anatomy and physiology in the
flight environment.
I stressed the complex interac-
tion between our visual, vestibular,
and proprioceptive systems and
their importance as it relates to ori-
entation. We explored the possible
consequences to a pilot who is im-
paired by hypoxia, fatigue, dehydra-
tion, or over-the-counter medica-
tions. I showed the students a short
video on pilots who met their fate
due to the graveyard spiral, and
other somatogravic illusions.
Throughout the classes, I tried
to relate basic anatomy and physi-
ology to the flight environment.







For his leadership and integrity in the airline industry,
commitment to employees, and his years of dedicated service
to the f lying public in promoting aviation safety for
passengers and crews. He is truly a pilot's pilot.
Awarded May 5, 2003
By the
Board of Trustees
Civil Aviation Medical Association
mal sleep cycles, we then discussed
circadian dysrhythmia and how in-
somnia and fatigue might affect
performance in flight.
The remaining classes covered
aviation medical topics. We re-
viewed medical risks associated
with air travel including: cabin air
quality, communicable diseases,
cosmic radiation, air rage, venous
thromboembolism, and bioterrorism.
The last class discussed the gen-
eral health of pilots and the medi-
cal certification process. We re-
viewed an 8500-8 form and listed
conditions that could disqualify
airmen from becoming FAA-certi-
fied. The students ended the course
with a 100-question, written, take-
home test.
The students have given tremen-
dously positive feedback. Two stu-
dents have already requested clinical
rotations in aerospace medicine this
summer. I am currently looking for
facilities that will be able to provide
them with practical experience.
I would like to share this cur-
riculum with any CAMA members
who are interested in teaching this
course. As this is an original out-
line and my first attempt at teach-
ing this topic, suggestions for im-
provement are welcome.
I've enjoyed this new teaching
experience and look forward to my
next class. It has been exciting to
see so many young physicians share
my interest in this field. I agree with
Dr. Dodge— It is good for our or-
ganization and our profession as a
whole to educate our medical stu-
dents to ensure that the aerospace
medical community will continue
to grow. FP
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FROM THE FLIGHT LINE
Fatigue Issues for Flight Crews
BY MARK BURMAN, PILOT- AMERICA WEST AIRLINES
How do flight crews and airlines prevent fatigue-related risks?
A commercial pilot gives the low-down.
BTIGUE ISSUES for flight crewsave existed almost since theawn of time. Over the_, ears, both aviators and the
medical professionals that certify
them as being fit to fly have become
more and more aware of the nega-
tive consequences that can occur
while pilots operate aircraft in a fa-
tigued state.
In recent years, as the science of
fatigue has advanced, terms like
MSOT (missed sleep opportunity)
and WOCL (window of circadian
low) have surfaced to describe pe-
riods where fatigue might be preva-
lent. In the airline business, we use
other terms to describe potentially
fatiguing flights. Terms are used
like Flip-Flop, Redeye, and the
newest one, Black Flag (which is
used to describe a set of flights con-
ducive to fatigue). Whatever you
call them, the risk factors increase
for pilots operating these flights.
So how do flight crews and air-
lines prevent fatigue-related risks?
At the airline where I fly, there is a
big difference of opinion between
the pilot group and management on
this issue. While management has
a written policy on fatigue and
safety, in practice it appears that
their commitment only goes as far
as the pen. Let me give some ex-
amples of what I mean.
The written policy is that when
pilots feel fatigued enough that they
are not safe to fly, they are required
to immediately call Scheduling and
get themselves replaced. Here is
were problems start at my airline.
Under our current contract, if a
pilot "calls in fatigued," they will
be removed from the fl ight or
flights, but will not be pay pro-
tected. Yes, if you call in fatigued,
you lose pay.
For many, this a very strong in-
centive NOT to make the call. In
truth, most pilots will call in sick
(as there is pay protection in doing
this) rather than call in fatigued,
or they will just fly the pairing fa-
tigued. The company continues to
make the argument that the trips
(or pairings as we refer to them) are
not fatiguing, as evidenced by the
very low number of fatigue calls.
Despite all of the data on sick
calls and a study showing that over
90% of our pilot group has flown
fatigued, the company stands be-
hind its belief that a fatigue prob-
lem does not exist. They continue
to cite the policy on calling in fa-
tigued. The study of pilots also
showed that about the same per-
centage, 90%, have fallen asleep
while acting as a crew member
while airborne.
Additionally, an equally large
percentage indicated that they co-
ordinate naps with other crew
members on flights where fatigue
is an issue. The company's response
to this data was, for the most part,
to question its validity.
The subject of fatigue is not ger-
mane to operations at my airline.
Every major airline deals with this
problem. Some attempt to mitigate
the effects of fatigue in l a t e -n igh t
flyers by scheduling only one leg.
For instance, on a late-night
flight from Los Angeles to Boston,
the crew would have no other
flights that day. At my airline, it is
common to start your day at around
7:00 p.m. and fly three legs. The
first from City A to B, next from B
to C, finally from C to D. The
flight from C to D is a late-night
flight from the Western US to the
East Coast.
This is the type of pairing called
a black flag pairing. To alleviate the
fatigue factor, our pilot representa-
tives have consistently asked that
the first two flights are flown by one
crew and the late-night flight done
by another.
The company has maintained for
some time that if the fl ight or
flights comply with FAA regula-
tions, then it is OK. From time to
time, we see improvements; however,
economics seem to dominate, and
the black flag pairings continue.
Here is some more data to re-
flect on. At my airline, 27% of the
trips assigned fly through a WOCL.
Additionally, 50% of the trips as-
signed are identified as pairings,
including MSOT. These numbers
are derived using established crite-
ria from NASA studies, as well as
leading industry standards for fa-
tigue criteria. FP
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Chronotherapeutics in Aviation Medicine
Circadian Variance and the Aviator
BY JAMES R. ALMAND, M.D.
One hour of sleep before midnight is worth two after.
—Ancient Proverb
SLEEP LOSS— sleep deprivation,or "sleep debt" —can affectone's reaction time, attention,
cognition, physiology, memory, and
alert status. This change can be
acute in the sleep-deprived indi-
vidual or it can be insidious.
All individuals react differently
to sleep times (e.g., from Dr. Alfred
Sweitzer, who averaged four hours
nightly to today's studies of eight
hours' recommended sleep). Some
individuals suffer neurobehavioral
changes from sleep loss differently
from others. Lost sleep has a cu-
mulative effect and accumulates as
sleep debt.
Insomnia includes complaints of
difficulty initiating sleep, maintain-
ing sleep, resuming sleep, or un-
refreshing sleep. Impairment in
functioning, fatigue, or somatic
symptoms can follow. Insomnia is
categorized as transient (a few
days), short term (longer — from
significant stressors), and long term
(months or years - from medical
of psychiatric cause). Untreated
sleep disorders can also be associ-
ated with medical problems, such
as heart disease, hypertension, and
strokes.
Insomnia therapies in use today
include older hypnotics (benzodi-
azepines), which can cause abuse
potential, hangover, impairment,
dizziness, and memory impairment.
More recent changes in hypnotics
evolved in the non-benzodiazepine
varieties, which offer greater safety
and fewer side effects, with far fewer
residual effects than benzodiazepines
— zolpidem (Ambien) and zaleplon
(Sonata) are in this class and produce
sedation through a neurochemical ef-
fect on the brain's GABA-a receptor.
Better prescribed normal sleep pat-
terns are an advantage of these newer
medications, with minimal side ef-
fects, tolerance rebound, and psycho-
motor performance.
Other non-prescribed sleep aids
include antihistamines (Unisom,
Benadryl , Nytol, Sleep Eze,
Sominex) and also herbs (valerian
and melatonin). Many studies to
date suggest that antihistamines
and herbs are associated with long-
term hangover and metabolic/he-
patic side effects.
Medical theories in the past
taught the concept that bodily
function was constantly in equilib-
rium throughout the 24-hour day.
Experience developed in the care-
ful study of circadian variance, both
in travel ("jet lag") or in one's own
biological clock, now has revised
that theory.
The human brain has an ind-
welling "pacemaker" for circadian
clock dependent alerting, which
resides in the suprachiasmatic
nucleus of the hypothalamus. This
endogenous biologic clock coordi-
nates the body's sleep and waken-
ing cycle. Lack of synchronism of
the human biologic clock (or
desynchronosis) develops when the
brain's circadian rhythm is out of
phase with the environment — and
termed "jet lag." Individuals adjust
to desynchronosis at differing lev-
els, with variable tolerance to cir-
cadian changes.
In the human body, cyclical bio-
logic functions are also tied to the
timing of drug administration for
achieving maximum physiologic
benefit. Timing of medication dos-
age in clinical aviation — civilian or
military — is vital to the aviator's
biologic cyclical circadian rhythm.
Examples of timing of drug dosages
to circadian bodily clocks are noted
in many aspects — e.g., diseases and
drugs such as anticoagulants, choles-
terol lowering medications, asthma
therapies, arthritics, antihyperten-
sives, and anginal medications.
Circadian early-morning awak-
ening is closely tied to bodily physi-
ological surges in blood pressure,
pulse, cortisol and catecholamine
levels, increased platelet aggrega-
tion, increased myocardial oxygen
demand, testosterone elevation, and
even blood viscosity.
Human diseases also exhibit cir-
cadian variances and historically
relate exacerbation of primary oc-
currences to the time of day or
night — e.g., epilepsy, myocardial
infarction, cardiac arrest, strokes,
migraine, early morning contrasted
with nighttime asthma, apnea, and
congestive heart failure, or daytime
hemorrhagic gastric ulceration, or
hypertensive emergencies.
The aviator faces circadian
changes in all flights that interrupt
Continued —>
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the individual's regular biologic
clock— early departures, overnight
flights, or short layovers before the
next starting "show." Add to this
the "phase advance" of travel circa-
dian factors is more notable in
flights to an eastern direction, caus-
ing increase in jet lag in traveling
east related to the brain's light-dark
melatonin cycle. This form of jet
lag results in increased sleepiness,
insomnia, fatigue, and gastrointes-
tinal problems, and it is more no-
table than in western travel.
On layovers, the flyer must learn
to accommodate his body to a
strange hotel, an early time to sleep
based on the next day's flight show,
daytime sleep, night-time or depar-
ture from a region distant by miles
and multiple time zone changes
from his domicile, and many other
personal or schedule-determined
factors — all of which pose a chal-
lenge to gain a satisfactory eight
hour required sleep or a satisfactory
flight performance the following day.
In aviation medicine, flight
crews have repeatedly discussed the
value of circadian bodily demands
in the flyer. Many flight crews, in
recognition of this factor com-
monly employ sleep assistance
drugs or herbs (Nytol, Stilnox,
Benadryl, chamomile, Kava Kava,
etc.), which are frequently secured
from overseas drug sources or pre-
scribed by their private physicians.
In many instances, this usage of
"sleep aids" is unknown or over-
looked (or accepted) by the flyer's
flight surgeon and this not entered
on the FAA's 8500 form. The safety
of this practice in aviators has
drawn the attention of the FAA and
the flight surgeon community, and
it can be an unacceptable practice.
Couple the above self-medication
for sleep to the use the following day
for stimulants (caffeine, etc.) - there
is a "triple-armed" concern in avia-
tion medicine interest regarding
"circadio-aviation" in all flyers' thera-
peutic use of medications.
Consider the stimulant use ("go
pil l") in the varied mi l i t a r ies
(Faulkland campaign, Afghanistan
war, etc.) as a defined positive fac-
tor in troop or aircrew performance
- this controlled medication regi-
men has strong historical evidence
of positive performance outcomes.
But certainly, such a practice of
controlled stimulants use in com-
mercial aviation is highly disap-
proved — plus would ring a lot of
bells in a random drug screen.
What is the human's limit to bio-
logic variance in time zone changes,
sleep deprivation, alteration in the
circadian homeostasis of human
physiology (or psyche), the use of
stimulants or stressors, or even use
of prolonged drug delivery systems
that function with plasma drug lev-
els over 24 hours?
Many questions still are unre-
solved regarding the human physi-
ology of bodily sleep cycle demands
- or alterations of the same. With
longer-duration intercontinental
flights in larger "super jumbo"
'CAMA SUNDAY' SPECIAL EDITION
Photos plus the complete text of the recent San Antonio
scientific program entitled IN-FLIGHT MEDICINE will be presented
in a rare "Extra" issue of the FlightSurgeon...com'mg soon!
aircraft occurring and documented
adverse passenger health develop-
ments reported (vascular, pulmo-
nary, cardiac, etc), few studies of
flight crew immediate, delayed, or
future health consequences are on-
going — radiation effects of pro-
longed high-altitude exposure is
but one long-term concern that
demands ongoing research.
Should not a similar concern be
present regarding chronic circadian
physiologic changes affecting flight
crews?
Today's challenge to the com-
mercial aviation community — and
their flight surgeons - is to better
educate the flyer concerning aspects
of long flight legs, insomnia or
circadian-induced issues, symptoms
of sleep deprivation, commonly
available "sleep aids," hazards of
hypnotics for sleep, FAA guidelines
on the subject, and (by all means)
actively participate in preventive
medicine for all pilots. Only in this
way can flight medicine accomplish
its true mission - keeping the flyer
healthy.
Currently, transient insomnia in
the aviator requires no treatment,
with usually only sleep hygiene
training being effective, but the
pilot population requires special
consideration in choosing any agent
for sleep improvement, due to their
requirement for a high degree of
alertness on awakening. FP
Visit CAMA's Web Site
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Suggestions and
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BY CHARLES E. BILLINGS, MD, THE OHIO STATE UNIVERSITY, COLUMBUS, OHIO
A viation is a very complex, highly distributed, highly dynamic domain similar to medicine.
Both domains are comprised of many diverse groups and individuals with agendas often in
competition. Both domains involve very real dangers for consumers.
I HAVE BEEN ASKED to dlSCUSScomplexity and safety in relation to health care. For over 40
years, I have worked to improve
aviation safety, both as a physician
and as a human factors specialist.
In 1997, 1 became involved in at-
tempts to improve patient safety.
Your hosts have asked me to dis-
cuss our work in adverse event re-
porting and how it might be ap-
plied in the medical domain.
Aviation is a very complex, highly
distributed, highly dynamic domain.
It is rather similar to medicine, which
also is complex, highly distributed
and highly dynamic. Both domains
are comprised of many diverse groups
and individuals with agendas that are
often in competition. Both domains
involve very real dangers for consum-
ers. The products produced by both
domains are essential and in both,
there has been continually increasing
demand for services.
Interestingly, each system has only
one major product. In aviation, that
product is the transport of people and
goods from one place to another. In
medicine, the product is the delivery
of services to enhance, maintain, or
restore health. All of the resources and
people in each system are devoted
more or less directly to delivering that
one product, and doing so economi-
cally, for both systems operate in de-
mand-based markets.
These two systems have been dra-
matically affected by the introduction
of a great deal of high technology. As
a result of organizational, manage-
rial, and technical advances, both
domains have become increasingly
opaque, even to the experts within
them. This has been an almost in-
evitable concomitant of increasing
complexity in many industries and,
I should say, in government as well.
Perrow, in 1984, pointed out that
accidents are normal under these con-
ditions. He wrote,
Our ability to organize (and man-
age) does not match the inherent
hazards of some of our organized
activities. Better organization will
always help any endeavor. But the
best is not good enough for some
activit ies we have decided to
pursue, (p. 10)
In other words, increasing com-
plexity and system opacity are threats
to system safety. Your problem, as
system managers, is to accomplish
four major tasks to:
• understand the system (or sys-
tems) for which you are responsible;
• understand how that system is
supposed to behave under all
conditions;
• understand how that system can
misbehave; and
• learn how to avoid or ameliorate
unwanted system behavior.
This is a tall order. You are ulti-
mately responsible for the safe, effi-
cient delivery of your product—even
though you may not have the knowl-
edge and skills to provide medical
care, just as most airline CEOs can-
not either pilot or maintain their air-
craft and other tools.
You are hindered in these tasks by
what Sydney Yoshida called "The Ice-
berg of Ignorance." His work sug-
gests that the following percentages
of an organization's operational prob-
lems are known to:
• Top managers: About 4%
• Middle managers: About 9%
• Supervisors: About 74%
• Front-line employees: Nearly 100%
In the 1999 revision of his book,
Normal Accidents, Perrow asks a ques-
tion that gets to the heart of learning
about safety problems in very com-
plex organizations:
How can we create the atmo-
sphere, the culture, that will allow
underlings to speak up, or copilots
to warn chief officers; get opera-
tors to see the whole system rather
than just their part of it; keep the
watcher of the autopilot alert ... ?
(p. 378)
Dr. Perrow, an organizational so-
ciologist, has neatly captured the rea-
son for establishing the NASA Avia-
tion Safety Reporting System.
What is the prevailing culture now
with respect to adverse events and
outcomes? Most people, I think, still
feel that punishment for serious er-
rors is an appropriate way to enforce
our society's attempts to maintain a
safe and healthful environment for
its citizens.
David North expressed this view-
point in an editorial last year in Avia-
tion Week and Space Technology, called
"Let (the) Judicial System Run Its
Course in Crash Cases." He said in
Part, "NTSB Chairman James Hall
has visited the U. S. Attorney
General's Office in Washington many
times to discourage prosecutors from
attempting to find criminal fault
while the board, industry and pilot
organizations are still trying to de-
termine the cause of an accident. Hall
and others contend that if blame or
threat of litigation is allowed to move
to the fore, people will be afraid to
talk to accident investigators. And
that will hinder the fact-finding that
is aimed at preventing similar crashes.
Hall is worried that the lawyers are
getting out of hand...
Continued —>
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However, I believe that the fail-
ure of SabreTech employees to put
caps on oxygen generators consti-
tuted willful negligence ... Prosecu-
tors were right to bring charges.
There has to be some fear that not
doing one's job correctly could lead
to prosecution. Aviation is not and
should not be exempt from legal
due process...
One would hope that attorneys
representing the survivors of an ac-
cident would not get in the way of
a safety investigation ... At some
point, the legal world may start to
interfere with the overarching goal
of improving safety ... For now,
though, the safety board should not
overreact to the Valujet criminal
prosecutions and upset the balance
of safety and blame. This would be
unfortunate because the NTSB and
judicial system have all of the nec-
essary tools to help aviation safety,
if they use them with wisdom.
(Unfortunately, they do not.)
Human Error Issues
The concept of human error as
causation implies that human error
is blameworthy, as expressed by Mr.
North in the aviation context, and
by the Institute of Medicine when it
said in its Executive Summary, "the
external environment should create
sufficient pressure to make errors costly
to health care organizations and pro-
viders, so they are compelled to take
action to improve safety."
I contend that this concept is
counterproductive because it can in-
hibit our efforts to understand the
real causes of unwanted occurrences.
But what should replace it? The IOM
spoke to the issue of understanding
immediately after the assertion cited
above: "At the same time, there is a
need to enhance knowledge and tools
to improve safety and break down
legal and cultural barriers that im-
pede safety improvement." Let me
suggest that it is very likely that this
need will not be satisfied if the previ-
ously expressed need (making errors
costly to compel action to improve
safety) is our primary goal. Why do
I think this is true?
It has been my experience that the
greatest "legal and cultural barrier"
to efforts to improve our understand-
ing of unwanted events is the culture
of blame, punishment and retribu-
tion that pervades our society and
which is now becoming even more
manifest in the criminalization of
professional (e.g., pilot, physician,
nurse) behavior when it is associated
with adverse events. It is noteworthy
that the pilot of an airline aircraft that
crashed while carrying out an instru-
ment approach in New Zealand in
1995 has just been tried (and fortu-
nately acquitted) on four manslaugh-
ter charges. The police secured the
cockpit voice recorder tapes through
the courts for its investigation, the
first time that this has happened. Can
you believe that this misuse of safety-
critical data will improve the climate
for aircraft accident investigation in
that nation?
I have come to believe that you
can't have it both ways. You can man-
date the reporting of adverse events,
then count and categorize them,
eliminate either the people or the be-
haviors associated with them, then
observe whatever improvement you
can find in your "error" counts, as
the IOM has recommended. Alter-
natively, you can take the imperfect
world as you find it, solicit voluntary
reports of incidents, use them as op-
portunities to learn about their pro-
cesses and causes, and focus your
remediation efforts on the system in
which errors occur.
This approach led us to develop a
voluntary, confidential, non-punitive
incident reporting system that for 25
years has brought to light undesired
behaviors and unwanted occurrences
in aviation, in order to learn what
latent and manifest factors were in-
volved in those incidents.
Incident Reporting as a Source of
Information and Learning
I do not advocate an "enlightened,
blame-free, humane approach to col-
lecting data about unwanted events"
for any philosophical reason. I
advocate confidential, voluntary re-
porting of adverse events simply be-
cause I know it works when the col-
lection and analysis system is de-
signed properly and implemented
sensitively. Because it works, it can
lead knowledgeable people like your-
selves to the information, insights,
and knowledge that you must have
to effect the improvements that poli-
ticians and society are demanding in
health care, largely as a result of the
IOM report. I should point out that
a similar hue and cry was raised by
the Congress and the public after the
crash of TWA flight 514 in 1974, and
that f uror led to our NASA team
being tasked to develop our Aviation
Safety Reporting System.
Figure 1 [see model, next page]
shows a model of the incident report-
ing system that we developed and are
still using to collect incident data in
civil aviation in the United States. I
believe strongly that incident report-
ing, analysis and interpretation must
follow some sort of closed loop
model like this in order to keep the
industry and its practitioners mo-
tivated to use it to share the infor-
mation they have.
Some important "first principles"
are embodied in this concept as real-
ized in the NASA Aviation Safety
Reporting System. I describe them
briefly because I think each is essen-
tial to the success of a voluntary ad-
verse event reporting system. They
include:
• The aviation community are the
stakeholders in an Incident Report-
ing System.
The aviation community has been
deeply involved in the design, imple-
mentation and use of our incident
reporting system since its inception
in 1975. Community representatives
act as a "board of overseers" and pro-
vide criticism, expertise and advocacy
for the system. They and we con-
sider themselves as the primary
stakeholders in the venture, along
Continued —>
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with the Federal Government which
supports our system and makes
heavy use of its data.
• The community are the providers of
information.
Nearly 100% of reporters are from
the pilot, dispatcher, flight attendant,
air traffic controller and aircraft main-
tenance engineering communities.
These are the occupational groups rep-
resented on our advisory committee,
whose members encourage their
groups to report to the system.
• The reporting system must be cred-
ible: Its objectivity must be paramount.
The choice of NASA, a research
agency without regulatory or enforce-
ment powers, as the parent organiza-
tion for ASRS helped the new report-
ing system to establish a reputation
for credibility and objectivity. Wide-
spread use of its publications has
helped to maintain that reputation
during its 25 years of service to the
community.
• The reporting system must be safe
and non-punitive.
NASA's unique role as a research
agency helped to foster the impression
that data provided to it would not be
misused, but the reporting system
went to considerable lengths to ensure
that this impression was correct. To
our knowledge, there has not been a
security breach in 25 years; none of
the over 500,000 persons who have
submitted reports has incurred per-
sonal harm as a result.
• The reporting system must be in-
dependent.
It was obvious in 1975 that a vol-
untary aviation incident reporting sys-
tem, to be successful, would have to
be independent of the many political
and other pressures that might arise
from its data and conclusions. This
assumption was proven correct when
ASRS released the results of a study
whose conclusions ran counter to the
strongly-held beliefs of its sponsor,
which tried to shut it down by remov-
ing immunity from its operations. I
believe now, as I did then, that to be





to report its results as
it sees them; it must be
independen t of the
many competing inter-
est groups in its com-
munity.
• Subject-matter ex-
perts classify, analyze &
interpret data.
Since its beginning,
our reporting system has
utilized highly experi-
enced, usually recently-retired, pilots,
controllers and other subject-matter
experts as its analysts, to ensure that
incoming reports are screened by
knowledgeable people who under-
stand the context of the reports. These
persons perform all of the primary
analyses of incoming data, and some
secondary analyses as well when their
insights suggest new avenues of in-
quiry. Other analyses are done by aca-
demic and other experts who utilize
special studies to collect data on top-
ics in which they are interested.
• The community receives ongoing
feedback from ASRS
No one particularly enjoys filling
out reports. It is vital that prospective
reporters see tangible evidence that
their reports are being used construc-
tively to improve safety. ASRS utilizes
many avenues of feedback to practi-
tioners and the aviation industry.
Among its most important feedback
mechanisms are the following.
• ASRS has issued over 1000 Alert
Bulletins
• Callback reaches 85,000 subscribers
each month
• The system has performed over 500
special studies of data
• The system routinely performs
quick-response studies for the NTSB,
FAA, the Congress, and many other
requesters
• DirectLine, a technical publication,







• The community has been given in-
centives to continue reporting to ASRS
In addition to disseminating the
results of its studies of incoming re-
ports, other incentives are built into
the system. These are specific to ASRS;
other incentives may be needed in
other contexts.
• Philanthropy: reporters identify
with the ASRS safety mission
• Confidentiality: reporters are pro-
tected from identification
• Prophylactic effect: reporters receive
limited immunity from punitive action
• Therapeutic effect: reporters learn
from their errors and share their
insights
Discussion
I believe that these principles are
paramount in the establishment and
maintenance of a voluntary reporting
system within a community which
finds a need for data concerning op-
erational problems and sensitive hu-
man factors issues. Such factors are
involved in 70-80% of the incidents
reported to ASRS, and in a roughly
equal percentage of accidents in avia-
tion and other complex domains.
Note that since this is a voluntary,
confidential system, we believe that
our first obligation is to protect all
reporter identities. Does this matter?
Our stakeholders clearly believe it
does. When the FAA established
Continued —>
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voluntary incident reporting as an in-
house activity in 1975, it received
perhaps 200 reports in a year. When
the NASA safety reporting program
replaced it a year later, we received
100 reports a week; this number now
averages 600 reports a week. The
FAA promised the same level of
confidentiality that we did—but it
is the enforcement agency for civil
aviation and it was not trusted by
the community.
We completely deidentify our re-
ports during intake processing, and
some have criticized this step. All pro-
cessed data from the ASRS are pub-
lic data; at least one large national
newspaper demands, and receives, the
data on a monthly basis. If the
public's interest is in what is really
going on in the aviation system, they
can find out without much difficulty.
All that they cannot learn from pro-
cessed data is who reported what,
who was directly involved, and the
exact date and time of an occurrence.
If one's primary interest is in assign-
ing blame or liability for specific oc-
currences, these data are useless. But
if that is not one's interest, what has
been lost by this approach? The data,
and our conclusions, are freely avail-
able to all who care to inquire.
Because our system is voluntary,
we cannot evaluate the incidence or
prevalence of such occurrences. More
important, however, the presence of
specific problems in the national avia-
tion system can be reliably inferred if
reports of such problems are received.
We can reasonably assume that the
number of reports of a given type of
occurrence represents a lower bound
for the frequency with which such
problems occur. Is this not what we
need to know to aim our analytic re-
sources toward the most important
problems? Do we really need precise
estimates of their incidence to decide
whether they are worth bothering
with? We have assumed (we think
correctly) that busy people do not
bother to report non-events, and that
our reporters are generally truthful in
their narratives.
Our analysts can contact report-
ers to ASRS before deidentifying their
reports, and they have done so on
thousands of occasions to obtain fur-
ther details of the occurrences
reported. These "callbacks" have
made it possible for us to do detailed
studies of problems that represent a
high potential for serious harm. We
often discuss deidentified incidents
with experts who can assess that po-
tential or who can suggest possible
solutions for the problems presented.
We publicize serious reports exten-
sively so that the community knows
of emerging threats and can watch
for them in their operations.
Finally, our analysts represent
several hundred years of aviation
experience. They share what they
are seeing with each other on a
daily basis (and with FAA dur-
ing frequent teleconferences).
These interactions make the ana-
lysts more sensitive to what they
see in incoming reports, and help
to provide insights into possible
causes or remedial actions. This
isn't tidy science, but it has been
quite remarkable in its effective-
ness. And effectiveness is what
we are after, not science. FP
This concludes Part I of this article. It
will be concluded in the next issue of
the FlightPhysician. Prepared for the
Premier CEO Leadership Forum, As-
pen, Colorado, September 11, 1991.
© Charles E. Billings, MD, 2001
CAMA CONSULTANTS
To our new members and as a reminder to all: This is a list of more experienced AMEs that have volunteered to help
with troublesome certification cases. For involved questions, E-mail or fax is preferred. This list is NOT for use by
airmen, but solely for AMEs within the CAMA membership.
































James L. Tucker, MD EST
Phone: 256-329-7788
E-mail: JLTucker@mindspring.com













FAA Aviation Medical Examiner
Seminar Schedule
2003
July 18-20 Chicago, 111. (Aviation Physiology/HF)
August 1 5 - 1 7 Washington, D.C./McLean, Va. (Cardio)
September 15-19 Oklahoma City, Okla. (Basic)
October 3 - 5 Salt Lake City, Utah (Ophth/Otolaryn/
Endocrin)








_ Oklahoma City, Okla.
_ Oklahoma City, Okla.
For information, call your regional flight surgeon. To
schedule a seminar, call the FAA Civil Aerospace Medical
Institute AME Programs Office ( 405) 954-4830
CAMA Headquarters
P.O. Box 23864
Oklahoma City, OK 73123-2864
Aerospace Medical Association's
Annual Meeting Schedule
May 2-6, 2004 Anchorage, Alaska
May 8-12, 2005 Kansas City, Missouri
Civil Aviation Medical Association's
Annual Meeting Schedule
October 8-12, 2003 _ Seattle, Washington,
Marriott Sea Tac Hotel
October 6-10, 2004 _ Omaha, Nebraska,
Marriott Omaha Hotel
October 5 - 9 , 2005 _ Charleston, South
Carolina, TEA
October 4 - 8, 2006 Ottawa, Canada,
Ottawa Marriott Hotel
New CAMA Members
Ahmed Elmonem Awad, M.D.





20000 North 57th Ave., #F105
Glendale, AZ 85308-6863
Phone: 623-572-3758











Aransas Pass, TX 78336-1569
Phone: 361-758-1585
General Surgery Pilot AME
